BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 27919572)

  • 1. Non-fucosylated CB CD34
    Robinson SN; Thomas MW; Simmons PJ; Lu J; Yang H; Javni JA; Shpall EJ; Zweidler-Mckay PA
    Cytotherapy; 2017 Feb; 19(2):285-292. PubMed ID: 27919572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow.
    Xia L; McDaniel JM; Yago T; Doeden A; McEver RP
    Blood; 2004 Nov; 104(10):3091-6. PubMed ID: 15280192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucosyltransferase VII improves the function of selectin ligands on cord blood hematopoietic stem cells.
    Wan X; Sato H; Miyaji H; McDaniel JM; Wang Y; Kaneko E; Gibson B; Mehta-D'Souza P; Chen Y; Dozmorov M; Miller LP; Goodman J; Sun Z; Xia L
    Glycobiology; 2013 Oct; 23(10):1184-91. PubMed ID: 23899669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice.
    Robinson SN; Simmons PJ; Thomas MW; Brouard N; Javni JA; Trilok S; Shim JS; Yang H; Steiner D; Decker WK; Xing D; Shultz LD; Savoldo B; Dotti G; Bollard CM; Miller L; Champlin RE; Shpall EJ; Zweidler-McKay PA
    Exp Hematol; 2012 Jun; 40(6):445-56. PubMed ID: 22306295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.
    Popat U; Mehta RS; Rezvani K; Fox P; Kondo K; Marin D; McNiece I; Oran B; Hosing C; Olson A; Parmar S; Shah N; Andreeff M; Kebriaei P; Kaur I; Yvon E; de Lima M; Cooper LJ; Tewari P; Champlin RE; Nieto Y; Andersson BS; Alousi A; Jones RB; Qazilbash MH; Bashir Q; Ciurea S; Ahmed S; Anderlini P; Bosque D; Bollard C; Molldrem JJ; Chen J; Rondon G; Thomas M; Miller L; Wolpe S; Simmons P; Robinson S; Zweidler-McKay PA; Shpall EJ
    Blood; 2015 May; 125(19):2885-92. PubMed ID: 25778529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment.
    Robinson SN; Thomas MW; Simmons PJ; Lu J; Yang H; Parmar S; Liu X; Shah N; Martín-Antonio B; Bollard C; Dotti G; Savoldo B; Cooper LJ; Najjar A; Rezvani K; Kaur I; McNiece IK; Champlin RE; Miller LP; Zweidler-McKay PA; Shpall EJ
    Cytotherapy; 2014 Jan; 16(1):84-9. PubMed ID: 24094497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial progenitor cells promote efficient ex vivo expansion of cord blood-derived hematopoietic stem/progenitor cells.
    Qu Q; Liu L; Chen G; Xu Y; Wu X; Wu D
    Cytotherapy; 2016 Mar; 18(3):452-64. PubMed ID: 26857234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in umbilical cord blood stem cell expansion and clinical translation.
    Pineault N; Abu-Khader A
    Exp Hematol; 2015 Jul; 43(7):498-513. PubMed ID: 25970610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles from human iPSCs enhance reconstitution capacity of cord blood-derived hematopoietic stem and progenitor cells.
    Karnas E; Sekuła-Stryjewska M; Kmiotek-Wasylewska K; Bobis-Wozowicz S; Ryszawy D; Sarna M; Madeja Z; Zuba-Surma EK
    Leukemia; 2021 Oct; 35(10):2964-2977. PubMed ID: 34140648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
    Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE
    Front Immunol; 2020; 11():573406. PubMed ID: 33193358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived CD34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of CD34+HSPCs.
    Bueno C; Montes R; Menendez P
    Stem Cell Rev Rep; 2010 Jun; 6(2):215-23. PubMed ID: 20180051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow.
    Hidalgo A; Frenette PS
    Blood; 2005 Jan; 105(2):567-75. PubMed ID: 15367439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells.
    Dykstra B; Lee J; Mortensen LJ; Yu H; Wu ZL; Lin CP; Rossi DJ; Sackstein R
    Stem Cells; 2016 Oct; 34(10):2501-2511. PubMed ID: 27335219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α-stabilizing agent FG-4497 rescues human CD34
    Nowlan B; Futrega K; Brunck ME; Walkinshaw G; Flippin LE; Doran MR; Levesque JP
    Exp Hematol; 2017 Aug; 52():50-55.e6. PubMed ID: 28527810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotransplantation of ex vivo expanded progenitors with nonexpanded cord blood cells improves platelet recovery.
    Émond H; Boyer L; Roy DC; Pineault N
    Stem Cells Dev; 2012 Nov; 21(17):3209-19. PubMed ID: 22783996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified CD34+ hematopoietic stem and progenitor cell isolation strategy from cryopreserved human umbilical cord blood.
    Mata MF; Hernandez D; Rologi E; Grandolfo D; Hassan E; Hua P; Kallmeier R; Hirani S; Heuts F; Tittrea V; Choo Y; Baradez MO; Watt SM; Tarunina M
    Transfusion; 2019 Dec; 59(12):3560-3569. PubMed ID: 31769050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid affects the engraftment of TPO-expanded cord blood cells in NOD/SCID mice.
    Vulcano F; Milazzo L; Ciccarelli C; Barca A; Agostini F; Altieri I; Macioce G; Di Virgilio A; Screnci M; De Felice L; Giampaolo A; Hassan HJ
    Exp Cell Res; 2012 Feb; 318(4):400-7. PubMed ID: 22166516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a surface antigen (MA6) by peripheral blood CD34+ cells is correlated with improved platelet engraftment and may explain delayed platelet engraftment following cord blood transplantation.
    Simmons PJ; Robinson SN; Munsell MF; Thomas MW; Javni JA; Brouard N; Zweidler-McKay PA; Shpall EJ
    Stem Cells Dev; 2015 May; 24(9):1066-72. PubMed ID: 25674667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.